| Apomyx,
Inc. |
Apomyx Inc. has international pioneer patents (variously allowed and pending) for its ApoSync(TM) technology, which
confers, stabilizes and controls apomixis (natural cloning of hybrid plants through their own seed).
The "genetic fixation" of hybrid vigor afforded by apomixis is expected to substantially reduce costs of hybrid seed
production for crops currently grown as hybrids. It is also expected to make economical the conversion of varietal
crops, e.g. wheat, rice and soybean, to hybrid crops with accompanying yield increases.
Apomyx plans to enter into strategic alliances with seed companies and to develop innovative apomictic seed
products for worldwide distribution and sale. Carman, professor of plant genetics, Utah State University, has published
research findings concerning apomixis for two decades. Based on his discoveries, he founded Apomyx Inc. on March
2, 1998. |
| May
01
Apomyx Inc.
appoints seed industry leader as CEO
(3540)
|
| . |
|
